CDH17 and familial pancreatic carcinoma: In vitro and in vivo experiments using pancreatic cancer cell lines have demonstrated that CDH-17-targeted NIR-PIT could induce specific cytotoxicity against CDH-17-expressing cells and inhibit tumor progression in a xenograft model of pancreatic cancer [154].